APP and neurodegenerative disease: Interestingly, AAV5-hRORA treatment attenuated accumulation of both A2E, the phototransduction waste product that damages RPE cells, as well as APP, the precursor to amyloid-β implicated in pathogenesis in retinal and neurodegenerative diseases [60, 63, 78].